HEADER VIRAL PROTEIN/IMMUNE SYSTEM 29-SEP-20 7K9K TITLE SARS-COV-2 SPIKE RBD IN COMPLEX WITH NEUTRALIZING FAB 2H04 (LOCAL TITLE 2 REFINEMENT) COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPIKE PROTEIN S1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RECEPTOR BINDING DOMAIN (UNP RESIDUES 333-527); COMPND 5 SYNONYM: S GLYCOPROTEIN,E2,PEPLOMER PROTEIN,SPIKE GLYCOPROTEIN; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: 2H04 HEAVY CHAIN; COMPND 9 CHAIN: H; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: 2H04 LIGHT CHAIN; COMPND 13 CHAIN: L; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 GENE: S, 2; SOURCE 7 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 8 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 10 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 13 ORGANISM_COMMON: MOUSE; SOURCE 14 ORGANISM_TAXID: 10090; SOURCE 15 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 16 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 18 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 21 ORGANISM_COMMON: MOUSE; SOURCE 22 ORGANISM_TAXID: 10090; SOURCE 23 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 24 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 25 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 26 EXPRESSION_SYSTEM_CELL_LINE: HEK293 KEYWDS SARS-COV-2, NEUTRALIZING ANTIBODY, RECEPTOR-BINDING DOMAIN, VIRAL KEYWDS 2 PROTEIN-IMMUNE SYSTEM COMPLEX, STRUCTURAL GENOMICS, CENTER FOR KEYWDS 3 STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID EXPDTA ELECTRON MICROSCOPY AUTHOR J.M.ERRICO,D.H.FREMONT,CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS AUTHOR 2 DISEASES (CSGID) REVDAT 3 10-NOV-21 7K9K 1 JRNL REVDAT 2 03-NOV-21 7K9K 1 JRNL REVDAT 1 29-SEP-21 7K9K 0 JRNL AUTH J.M.ERRICO,H.ZHAO,R.E.CHEN,Z.LIU,J.B.CASE,M.MA,A.J.SCHMITZ, JRNL AUTH 2 M.J.RAU,J.A.J.FITZPATRICK,P.Y.SHI,M.S.DIAMOND,S.P.J.WHELAN, JRNL AUTH 3 A.H.ELLEBEDY,D.H.FREMONT JRNL TITL STRUCTURAL MECHANISM OF SARS-COV-2 NEUTRALIZATION BY TWO JRNL TITL 2 MURINE ANTIBODIES TARGETING THE RBD. JRNL REF CELL REP V. 37 09881 2021 JRNL REFN ESSN 2211-1247 JRNL PMID 34655519 JRNL DOI 10.1016/J.CELREP.2021.109881 REMARK 2 REMARK 2 RESOLUTION. 3.14 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : EPU, GCTF, RELION, RELION, RELION, REMARK 3 CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.140 REMARK 3 NUMBER OF PARTICLES : 304667 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: C3 EXPANDED PARTICLES REMARK 4 REMARK 4 7K9K COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-SEP-20. REMARK 100 THE DEPOSITION ID IS D_1000251988. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : COMPLEX OF SARS-COV-2 SPIKE RBD REMARK 245 WITH FAB FRAGMENT OF MONOCLONAL REMARK 245 ANTIBODY 2H04; SARS-COV-2 SPIKE REMARK 245 RBD; FAB FRAGMENT OF MONOCLONAL REMARK 245 ANTIBODY 2H04 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 1.00; 0.20 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : 20S WAIT TIME 2S BLOT TIME; 20S REMARK 245 WAIT TIME 2S BLOT TIME REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50; 7.50 REMARK 245 SAMPLE DETAILS : FAB FRAGMENTS GENERATED BY REMARK 245 PROTEOLYTIC CLEAVAGE OF RECOMBINANTLY EXPRESSED IGG REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 SUMMIT (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 0.01 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6700.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : 105000 REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, H, L, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 469 REMARK 465 THR A 470 REMARK 465 GLU A 471 REMARK 465 ILE A 472 REMARK 465 TYR A 473 REMARK 465 GLN A 474 REMARK 465 ALA A 475 REMARK 465 GLY A 476 REMARK 465 SER A 477 REMARK 465 THR A 478 REMARK 465 PRO A 479 REMARK 465 CYS A 480 REMARK 465 ASN A 481 REMARK 465 GLY A 482 REMARK 465 VAL A 483 REMARK 465 GLU A 484 REMARK 465 GLY A 485 REMARK 465 PHE A 486 REMARK 465 ASN A 487 REMARK 465 CYS A 488 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER H 17 O LEU H 83 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 343 32.86 -98.18 REMARK 500 SER H 55 -3.86 -141.13 REMARK 500 THR H 77 60.37 60.79 REMARK 500 LEU L 11 74.42 -107.80 REMARK 500 ASN L 41 -4.88 67.29 REMARK 500 ALA L 51 -8.09 72.64 REMARK 500 THR L 69 -34.92 -131.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-22751 RELATED DB: EMDB REMARK 900 RELATED ID: IDP51002 RELATED DB: TARGETTRACK REMARK 900 RELATED ID: EMD-22748 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-22749 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-22750 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-22752 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-22753 RELATED DB: EMDB REMARK 900 RELATED ID: 7K9H RELATED DB: PDB REMARK 900 RELATED ID: 7K9I RELATED DB: PDB REMARK 900 RELATED ID: 7K9J RELATED DB: PDB DBREF 7K9K A 333 527 UNP P0DTC2 SPIKE_SARS2 333 527 DBREF 7K9K H 1 121 PDB 7K9K 7K9K 1 121 DBREF 7K9K L 1 106 PDB 7K9K 7K9K 1 106 SEQRES 1 A 195 THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA THR SEQRES 2 A 195 ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG ILE SEQRES 3 A 195 SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SER SEQRES 4 A 195 ALA SER PHE SER THR PHE LYS CYS TYR GLY VAL SER PRO SEQRES 5 A 195 THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR ALA SEQRES 6 A 195 ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN ILE SEQRES 7 A 195 ALA PRO GLY GLN THR GLY LYS ILE ALA ASP TYR ASN TYR SEQRES 8 A 195 LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA TRP SEQRES 9 A 195 ASN SER ASN ASN LEU ASP SER LYS VAL GLY GLY ASN TYR SEQRES 10 A 195 ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU LYS SEQRES 11 A 195 PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN ALA SEQRES 12 A 195 GLY SER THR PRO CYS ASN GLY VAL GLU GLY PHE ASN CYS SEQRES 13 A 195 TYR PHE PRO LEU GLN SER TYR GLY PHE GLN PRO THR ASN SEQRES 14 A 195 GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SER SEQRES 15 A 195 PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY PRO SEQRES 1 H 121 GLU VAL GLN LEU GLN GLN SER GLY ALA GLU LEU VAL LYS SEQRES 2 H 121 PRO GLY ALA SER VAL LYS MET SER CYS LYS ALA SER GLY SEQRES 3 H 121 TYR THR PHE THR SER TYR TRP ILE THR TRP VAL LYS GLN SEQRES 4 H 121 ARG PRO GLY GLN GLY LEU GLU TRP ILE GLY ASP ILE TYR SEQRES 5 H 121 PRO GLY SER GLY SER THR LYS TYR ASN GLU LYS PHE ARG SEQRES 6 H 121 SER GLU ALA THR LEU THR VAL ASP THR SER SER THR THR SEQRES 7 H 121 ALA TYR MET GLN LEU SER SER LEU THR SER GLU ASP SER SEQRES 8 H 121 ALA VAL TYR TYR CYS ALA ARG TRP ASP PHE TYR GLY SER SEQRES 9 H 121 ARG THR PHE ASP TYR TRP GLY GLN GLY THR THR LEU THR SEQRES 10 H 121 VAL SER SER ALA SEQRES 1 L 106 ASP ILE VAL LEU THR GLN SER PRO ALA ILE LEU SER VAL SEQRES 2 L 106 SER PRO GLY GLU ARG VAL SER PHE SER CYS ARG ALA SER SEQRES 3 L 106 GLN ASN ILE GLY THR ILE ILE HIS TRP TYR GLN GLN ARG SEQRES 4 L 106 THR ASN GLY SER PRO ARG LEU LEU ILE LYS TYR ALA SER SEQRES 5 L 106 GLU SER VAL SER GLY ILE PRO SER ARG PHE SER GLY SER SEQRES 6 L 106 GLY SER GLY THR ASP PHE THR LEU SER ILE ASN SER VAL SEQRES 7 L 106 GLU SER GLU ASP ILE ALA ASP TYR TYR CYS GLN GLN SER SEQRES 8 L 106 SER SER TRP PRO LEU THR PHE GLY ALA GLY THR LYS LEU SEQRES 9 L 106 GLU LEU HET NAG B 1 14 HET NAG B 2 14 HET BMA B 3 11 HET FUC B 4 10 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 4 NAG 2(C8 H15 N O6) FORMUL 4 BMA C6 H12 O6 FORMUL 4 FUC C6 H12 O5 HELIX 1 AA1 PRO A 337 ASN A 343 1 7 HELIX 2 AA2 SER A 349 TRP A 353 5 5 HELIX 3 AA3 ASP A 364 SER A 371 1 8 HELIX 4 AA4 THR A 385 ASP A 389 5 5 HELIX 5 AA5 ASP A 405 ALA A 411 5 7 HELIX 6 AA6 GLY A 416 ASN A 422 1 7 HELIX 7 AA7 GLU H 62 ARG H 65 5 4 HELIX 8 AA8 GLU L 79 ASP L 82 5 4 SHEET 1 AA1 5 ASN A 354 ILE A 358 0 SHEET 2 AA1 5 VAL A 395 ARG A 403 -1 O VAL A 395 N ILE A 358 SHEET 3 AA1 5 PRO A 507 PHE A 515 -1 O VAL A 512 N ASP A 398 SHEET 4 AA1 5 GLY A 431 ASN A 437 -1 N ILE A 434 O VAL A 511 SHEET 5 AA1 5 THR A 376 TYR A 380 -1 N TYR A 380 O GLY A 431 SHEET 1 AA2 3 CYS A 361 VAL A 362 0 SHEET 2 AA2 3 VAL A 524 CYS A 525 1 N CYS A 525 O CYS A 361 SHEET 3 AA2 3 CYS A 391 PHE A 392 -1 N PHE A 392 O VAL A 524 SHEET 1 AA3 2 LEU A 452 ARG A 454 0 SHEET 2 AA3 2 LEU A 492 SER A 494 -1 O GLN A 493 N TYR A 453 SHEET 1 AA4 4 GLN H 3 GLN H 6 0 SHEET 2 AA4 4 VAL H 18 SER H 25 -1 O LYS H 23 N GLN H 5 SHEET 3 AA4 4 THR H 78 LEU H 83 -1 O MET H 81 N MET H 20 SHEET 4 AA4 4 ALA H 68 ASP H 73 -1 N THR H 71 O TYR H 80 SHEET 1 AA5 6 ALA H 9 VAL H 12 0 SHEET 2 AA5 6 THR H 114 VAL H 118 1 O THR H 117 N GLU H 10 SHEET 3 AA5 6 ALA H 92 TRP H 99 -1 N TYR H 94 O THR H 114 SHEET 4 AA5 6 TRP H 33 ARG H 40 -1 N THR H 35 O ALA H 97 SHEET 5 AA5 6 GLN H 43 ILE H 51 -1 O GLU H 46 N LYS H 38 SHEET 6 AA5 6 THR H 58 TYR H 60 -1 O LYS H 59 N ASP H 50 SHEET 1 AA6 4 ALA H 9 VAL H 12 0 SHEET 2 AA6 4 THR H 114 VAL H 118 1 O THR H 117 N GLU H 10 SHEET 3 AA6 4 ALA H 92 TRP H 99 -1 N TYR H 94 O THR H 114 SHEET 4 AA6 4 TYR H 109 TRP H 110 -1 O TYR H 109 N ARG H 98 SHEET 1 AA7 4 THR L 5 GLN L 6 0 SHEET 2 AA7 4 VAL L 19 ARG L 24 -1 O ARG L 24 N THR L 5 SHEET 3 AA7 4 ASP L 70 ILE L 75 -1 O PHE L 71 N CYS L 23 SHEET 4 AA7 4 PHE L 62 SER L 67 -1 N SER L 65 O THR L 72 SHEET 1 AA8 6 ILE L 10 SER L 12 0 SHEET 2 AA8 6 THR L 102 GLU L 105 1 O LYS L 103 N LEU L 11 SHEET 3 AA8 6 ALA L 84 GLN L 90 -1 N TYR L 86 O THR L 102 SHEET 4 AA8 6 ILE L 33 ARG L 39 -1 N GLN L 38 O ASP L 85 SHEET 5 AA8 6 ARG L 45 LYS L 49 -1 O LEU L 47 N TRP L 35 SHEET 6 AA8 6 GLU L 53 SER L 54 -1 O GLU L 53 N LYS L 49 SHEET 1 AA9 4 ILE L 10 SER L 12 0 SHEET 2 AA9 4 THR L 102 GLU L 105 1 O LYS L 103 N LEU L 11 SHEET 3 AA9 4 ALA L 84 GLN L 90 -1 N TYR L 86 O THR L 102 SHEET 4 AA9 4 THR L 97 PHE L 98 -1 O THR L 97 N GLN L 90 SSBOND 1 CYS A 336 CYS A 361 1555 1555 2.04 SSBOND 2 CYS A 379 CYS A 432 1555 1555 2.05 SSBOND 3 CYS A 391 CYS A 525 1555 1555 2.03 SSBOND 4 CYS H 22 CYS H 96 1555 1555 2.04 SSBOND 5 CYS L 23 CYS L 88 1555 1555 2.03 LINK ND2 ASN A 343 C1 NAG B 1 1555 1555 1.44 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.46 LINK O6 NAG B 1 C1 FUC B 4 1555 1555 1.43 LINK O4 NAG B 2 C1 BMA B 3 1555 1555 1.45 CISPEP 1 SER L 7 PRO L 8 0 29.78 CISPEP 2 TRP L 94 PRO L 95 0 -7.74 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000